- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/06 - Antiasthmatics
Patent holdings for IPC class A61P 11/06
Total number of patents in this class: 3892
10-year publication summary
|
96
|
170
|
214
|
204
|
222
|
207
|
185
|
175
|
180
|
33
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AstraZeneca AB | 2829 |
99 |
| F. Hoffmann-La Roche AG | 7879 |
78 |
| Chiesi Farmaceutici S.p.A. | 962 |
59 |
| Boehringer Ingelheim International GmbH | 4580 |
49 |
| Daiichi Sankyo Company, Limited | 1875 |
49 |
| Genentech, Inc. | 4050 |
44 |
| Regeneron Pharmaceuticals, Inc. | 4541 |
32 |
| Takeda Pharmaceutical Company Limited | 2715 |
30 |
| Novartis AG | 10462 |
27 |
| The Regents of the University of California | 20427 |
26 |
| Theravance Biopharma R&D IP, LLC | 438 |
26 |
| Glaxo Group Limited | 4262 |
25 |
| Hoffmann-La Roche Inc. | 3628 |
25 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3259 |
25 |
| Bristol-myers Squibb Company | 4792 |
24 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
23 |
| Astellas Pharma Inc. | 1048 |
21 |
| Dainippon Sumitomo Pharma Co., Ltd. | 176 |
21 |
| KYORIN Pharmaceutical Co., Ltd. | 167 |
19 |
| Nippon Shinyaku Co., Ltd. | 323 |
19 |
| Other owners | 3171 |